GMP Documentation, Identity Testing Continue To Trip Supplement Firms
This article was originally published in The Tan Sheet
Warnings from FDA's Office of Regulatory Affairs make clear that failing to document compliance with each GMP requirement renders those parts of the process noncompliant. Warning letters posted March 22 also include FDA's latest enforcement against firms marketing bulk caffeine.
Register for our free email digests: